| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |